Physician profile
Haley B David
NPI 1366037038
$1,860.68
in general payments reported to CMS, 2019-2025
20 companies · $591 in 2025
The $591 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $156 · 2022: $417 · 2023: $339 · 2024: $358 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,287.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $350.78 | 2022-2025 | Caplyta |
| Abbvie INC. | $248.02 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $230.01 | 2022-2025 | |
| Amgen INC. | $154.41 | 2021-2022 | |
| Dexcom, INC. | $150.00 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Otsuka America Pharmaceutical, INC. | $129.40 | 2022-2025 | Rexulti, Abilify Asimtufii |
| Axsome Therapeutics, INC. | $120.74 | 2024 | Auvelity |
| Alkermes, INC. | $101.24 | 2023-2025 | Aristada, Lybalvi |
| Lilly USA, LLC | $77.68 | 2022-2023 | Mounjaro, Jardiance |
| Abbott Laboratories | $67.69 | 2022-2024 | Freestyle Libre 3 |
| Exact Sciences Corporation | $66.54 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $31.93 | 2023 | |
| Lundbeck LLC | $22.82 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.00 | 2024 | Jardiance |
| Novo Nordisk INC | $17.44 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $16.74 | 2025 | Airsupra |
| Vanda Pharmaceuticals INC. | $15.87 | 2024 | Fanapt |
| Astellas Pharma US INC | $15.51 | 2024 | Veozah |
| Ironshore Pharmaceuticals INC. | $14.59 | 2024 | |
| Corium, LLC | $9.27 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.